{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "united-states-federal", "type": "definition", "offset": [10, 31]}, {"key": "as-amended", "type": "definition", "offset": [61, 71]}], "samples": [{"hash": "fxqIExDwTNd", "uri": "/contracts/fxqIExDwTNd#fdc-act", "label": "Research, Collaboration & License Agreement (Solid Biosciences Inc.)", "score": 36.175907135, "published": true}, {"hash": "dPLAmUnem5k", "uri": "/contracts/dPLAmUnem5k#fdc-act", "label": "Research, Collaboration & License Agreement (Passage BIO, Inc.)", "score": 35.8665313721, "published": true}, {"hash": "7yG7QGTmMkL", "uri": "/contracts/7yG7QGTmMkL#fdc-act", "label": "Research, Collaboration & License Agreement (Passage BIO, Inc.)", "score": 35.8665313721, "published": true}], "size": 903, "snippet": "means the United States Federal Food, Drug and Cosmetic Act, as amended.", "hash": "0be2e9bc81074fb580729671608401d6", "id": 1}, {"snippet_links": [{"key": "the-us", "type": "clause", "offset": [6, 13]}, {"key": "as-amended", "type": "definition", "offset": [79, 89]}, {"key": "from-time-to-time", "type": "clause", "offset": [90, 107]}, {"key": "the-rules", "type": "clause", "offset": [113, 122]}, {"key": "guidance-documents", "type": "definition", "offset": [149, 167]}, {"key": "policy-guides", "type": "clause", "offset": [183, 196]}], "samples": [{"hash": "d7tHyE85zMj", "uri": "/contracts/d7tHyE85zMj#fdc-act", "label": "Credit Agreement and Guaranty (Exagen Inc.)", "score": 37.1861724854, "published": true}, {"hash": "fV53araHk66", "uri": "/contracts/fV53araHk66#fdc-act", "label": "Second Amendment to Credit Agreement and Guaranty (SOPHiA GENETICS SA)", "score": 37.0739212036, "published": true}, {"hash": "9MHJqgAgoAg", "uri": "/contracts/9MHJqgAgoAg#fdc-act", "label": "Credit Agreement (Exagen Inc.)", "score": 36.3210144043, "published": true}], "size": 326, "snippet": "means the U.S. Food, Drug and Cosmetic Act of 1938 (or any successor thereto), as amended from time to time, and the rules, regulations, guidelines, guidance documents and compliance policy guides issued or promulgated thereunder.", "hash": "14c65c2d3f3cd474ba7f8ec03ce970af", "id": 2}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "as-amended", "type": "definition", "offset": [80, 90]}, {"key": "rules-and-regulations", "type": "definition", "offset": [100, 121]}], "samples": [{"hash": "1pgJyXuPhyy", "uri": "/contracts/1pgJyXuPhyy#fdc-act", "label": "Co Development and Co Commercialization Agreement", "score": 31.3408622742, "published": true}, {"hash": "1cjvx82WzGa", "uri": "/contracts/1cjvx82WzGa#fdc-act", "label": "Collaboration and License Agreement (Lexicon Pharmaceuticals, Inc./De)", "score": 21.353181839, "published": true}, {"hash": "fvMI8zKYVhy", "uri": "/contracts/fvMI8zKYVhy#fdc-act", "label": "Co Development and Co Commercialization Agreement (Alexion Pharmaceuticals Inc)", "score": 21.0, "published": true}], "size": 129, "snippet": "means the United States Food, Drug and Cosmetic Act (or any successor thereto), as amended, and the rules and regulations promulgated thereunder.", "hash": "32319e5d8926d6ffccc4f992f5567701", "id": 3}, {"snippet_links": [{"key": "united-states-federal", "type": "definition", "offset": [10, 31]}, {"key": "as-amended", "type": "definition", "offset": [62, 72]}, {"key": "from-time-to-time", "type": "clause", "offset": [73, 90]}, {"key": "the-regulations", "type": "clause", "offset": [96, 111]}], "samples": [{"hash": "kkMw8atYJYc", "uri": "/contracts/kkMw8atYJYc#fdc-act", "label": "Drug Discovery and Development Option and License Agreement (Array Biopharma Inc)", "score": 24.8329906464, "published": true}, {"hash": "i1c3W2fLJ2u", "uri": "/contracts/i1c3W2fLJ2u#fdc-act", "label": "Collaboration and License Agreement (Cv Therapeutics Inc)", "score": 21.0, "published": true}, {"hash": "hcLjzEiWZcl", "uri": "/contracts/hcLjzEiWZcl#fdc-act", "label": "Drug Discovery and Development Agreement (Array Biopharma Inc)", "score": 21.0, "published": true}], "size": 65, "snippet": "means the United States Federal Food, Drug, and Cosmetic Act, as amended from time to time, and the regulations promulgated thereunder, as amended from time to time.", "hash": "8df41c8ffdcbe54b3f45d95d60c2be2d", "id": 4}, {"snippet_links": [{"key": "united-states-federal", "type": "definition", "offset": [10, 31]}, {"key": "as-amended", "type": "definition", "offset": [62, 72]}], "samples": [{"hash": "7jUON6fj1x0", "uri": "/contracts/7jUON6fj1x0#fdc-act", "label": "Exclusive License Agreement (Innate Pharma SA)", "score": 35.2559890747, "published": true}, {"hash": "fQ0YWs5qXUk", "uri": "/contracts/fQ0YWs5qXUk#fdc-act", "label": "Collaboration and License Agreement (Generate Biomedicines, Inc.)", "score": 35.0930862427, "published": true}, {"hash": "crt8KOSAx4W", "uri": "/contracts/crt8KOSAx4W#fdc-act", "label": "License and Research Collaboration Agreement (RayzeBio, Inc.)", "score": 34.6427116394, "published": true}], "size": 34, "snippet": "means the United States Federal Food, Drug, and Cosmetic Act, as amended.", "hash": "9fff680085cde0a39af16c3debbc5e86", "id": 5}, {"snippet_links": [], "samples": [{"hash": "fYWqa2WDMHs", "uri": "/contracts/fYWqa2WDMHs#fdc-act", "label": "Asset Purchase Agreement", "score": 33.1155891418, "published": true}, {"hash": "dg2aDjbz2MH", "uri": "/contracts/dg2aDjbz2MH#fdc-act", "label": "Merger Agreement (Motif Bio PLC)", "score": 27.5516777039, "published": true}, {"hash": "6Po5JQPNoFQ", "uri": "/contracts/6Po5JQPNoFQ#fdc-act", "label": "Merger Agreement (Motif Bio PLC)", "score": 27.5297737122, "published": true}], "size": 25, "snippet": "means the Federal Food, Drug and Cosmetic Act, 21 USC \u00a7 321 et seq.", "hash": "72721f0a459749f0c38d98f8d7522927", "id": 6}, {"snippet_links": [{"key": "the-us", "type": "clause", "offset": [6, 13]}, {"key": "as-amended", "type": "definition", "offset": [52, 62]}, {"key": "applicable-regulations", "type": "definition", "offset": [68, 90]}, {"key": "the-fda", "type": "clause", "offset": [117, 124]}], "samples": [{"hash": "3g1m83gw29K", "uri": "/contracts/3g1m83gw29K#fdc-act", "label": "Research License Agreement (Liquidia Corp)", "score": 34.3470230103, "published": true}, {"hash": "leECdo67oNW", "uri": "/contracts/leECdo67oNW#fdc-act", "label": "License and Collaboration Agreement (Alpine Immune Sciences, Inc.)", "score": 33.2053375244, "published": true}, {"hash": "8MRd8mvYICJ", "uri": "/contracts/8MRd8mvYICJ#fdc-act", "label": "Collaboration and License Agreement (Arrowhead Pharmaceuticals, Inc.)", "score": 32.5920600891, "published": true}], "size": 21, "snippet": "means the U.S. Federal Food, Drug and Cosmetic Act, as amended, and applicable regulations promulgated thereunder by the FDA.", "hash": "510505b948ec41cb9ac6bc209c8d8df2", "id": 7}, {"snippet_links": [{"key": "as-amended", "type": "definition", "offset": [74, 84]}], "samples": [{"hash": "1L2zxykQM55", "uri": "/contracts/1L2zxykQM55#fdc-act", "label": "Credit Agreement (Eton Pharmaceuticals, Inc.)", "score": 37.2847366333, "published": true}, {"hash": "gObub1Ggnop", "uri": "/contracts/gObub1Ggnop#fdc-act", "label": "Credit Agreement (Eton Pharmaceuticals, Inc.)", "score": 33.3586578369, "published": true}, {"hash": "bYqJYOXgUwQ", "uri": "/contracts/bYqJYOXgUwQ#fdc-act", "label": "Credit Agreement (Misonix Inc)", "score": 30.7357978821, "published": true}], "size": 21, "snippet": "means the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. \u00a7\u00a7 301 et seq., as amended.", "hash": "9ba59ce87023234b58656502226c5b59", "id": 8}, {"snippet_links": [], "samples": [{"hash": "kvrYBpPkzF1", "uri": "/contracts/kvrYBpPkzF1#fdc-act", "label": "Asset Purchase Agreement", "score": 31.3408622742, "published": true}, {"hash": "jJfXw2MKhsl", "uri": "/contracts/jJfXw2MKhsl#fdc-act", "label": "Asset Purchase Agreement (Coca Cola Bottling Co Consolidated /De/)", "score": 28.7563304901, "published": true}, {"hash": "igL9HFX8Tpf", "uri": "/contracts/igL9HFX8Tpf#fdc-act", "label": "Asset Exchange Agreement (Coca Cola Bottling Co Consolidated /De/)", "score": 28.7563304901, "published": true}], "size": 20, "snippet": "has the meaning set forth in Section 3.16(b).", "hash": "9f3d4ea9aabfda7316402d20f9c586fd", "id": 9}, {"snippet_links": [{"key": "as-amended", "type": "definition", "offset": [65, 75]}, {"key": "from-time-to-time", "type": "clause", "offset": [76, 93]}], "samples": [{"hash": "hd3woY3c570", "uri": "/contracts/hd3woY3c570#fdc-act", "label": "License, Development and Commercialization Agreement (Vanda Pharmaceuticals Inc.)", "score": 23.5872688293, "published": true}, {"hash": "5zXmoowRygZ", "uri": "/contracts/5zXmoowRygZ#fdc-act", "label": "Sublicense Agreement (Vanda Pharmaceuticals Inc.)", "score": 21.1998634338, "published": true}, {"hash": "8pp08mL4dsu", "uri": "/contracts/8pp08mL4dsu#fdc-act", "label": "Worldwide License Agreement (Titan Pharmaceuticals Inc)", "score": 18.0, "published": true}], "size": 19, "snippet": "means the Federal Food, Drug and Cosmetic Act (21 U.S.C. 301ff), as amended from time to time.", "hash": "fb1ce8cd42d9ed9cd39b80ebe77f1c85", "id": 10}], "next_curs": "ClQSTmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjALEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIQZmRjLWFjdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "FD&C Act", "size": 1902, "snippet": "means the United States Federal Food, Drug and Cosmetic Act, as amended.", "id": "fdc-act", "examples": ["Provider represents and warrants that at the time of shipment by Provider, each Batch of Product (i) will have been Manufactured in accordance with the Manufacturing Requirements, (ii) will not be adulterated or misbranded under FD&C Act or other Applicable Law [***] and (iii) will be free of liens and encumbrances."], "related": [["ffdca", "FFDCA", "FFDCA"], ["fdca", "FDCA", "FDCA"], ["fda-act", "FDA Act", "FDA Act"], ["new-drug-application", "New Drug Application", "New Drug Application"], ["drug-application", "Drug Application", "Drug Application"]], "related_snippets": [], "updated": "2026-04-30T06:05:53+00:00"}, "json": true, "cursor": ""}}